“Surgery remains the cornerstone of potentially curative therapy for solid malignancies… After all, the only patients who need future advances in cancer science and technology are the ones that were not cured by surgical resection in the first place.”
Complete surgical resection of solid tumours still cures more patients than all other therapies combined. For hundreds of years, surgery has been central to cancer treatment, with effective treatments other than resection have only become available in the recent history of oncology.
Surgical investigators lead or actively participate in basic and translational cancer research efforts. Many more surgeons actively participate in the design, implementation, and accrual of patients to clinical trials.
Other cancer surgeons are leaders in health services and health outcomes research, generating information about patient outcomes, quality of care, and the economics of cancer care delivery. As such, surgeons are involved in every aspect of research and treatment.
Cancer surgeons are often involved in patient care throughout the continuum of diagnosis, treatment, adjuvant therapy, and long-term follow-up. Therefore, we should not overlook the opportunity to engage the surgical community in the search for better care for patients with cancer.